Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Recruiting1
Unknown1
Active Not Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT01273610Phase 2Active Not Recruiting

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

NCT06490783RecruitingPrimary

Cyber-Human Systems for Personalized Well-being and Health

NCT05626946UnknownPrimary

Does the Intervention of an Advanced Practice Nurse for Nursing Home Residents Aged 75 and Over in the Grand Nancy Area Make it Possible to Reduce the Use of the Emergency Service for These Residents?

Showing all 3 trials

Research Network

Activity Timeline